Jessica K. Altman, MD
Associate Professor of Medicine
Division of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Director, Acute Leukemia Program
Robert H Lurie Cancer Center of Northwestern University
Chicago, Illinois

Richard M. Stone, MD
Professor of Medicine
Harvard Medical School
Chief of Staff and Director
Adult Acute Leukemia Program
Dana-Farber Cancer Institute
Boston, Massachusetts

Disclosure of Relevant Financial Relationships

All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

The faculty listed below have disclosed the following relevant financial relationships:

Jessica K. Altman, MD: Astellas Pharma US, Inc.: Scientific Advisor; Bristol-Myers Squibb Company: Scientific Advisor; Fujifilm Corporation: Scientific Advisor; Janssen Pharmaceutica Products, LP: Scientific Advisor; Syros Pharmaceuticals: Scientific Advisor.

Richard M. Stone, MD: Agios Pharmaceuticals, Inc.: Consulting Fees, Honoraria; Amgen, Inc.: Consulting Fees, Honoraria; Arog Pharmaceuticals, Inc.: Consulting Fees, Honoraria; Bristol-Myers Squibb Company: Consulting Fees, Honoraria; Celator Pharmaceuticals, Inc.: Consulting Fees, Honoraria; Celgene Corporation: Consulting Fees, Honoraria; Fujifilm Corporation: Consulting Fees, Honoraria; Janssen Pharmaceutica Products, LP: Consulting Fees, Honoraria; Karyopharm Therapeutics: Consulting Fees, Honoraria; Merck & Co., Inc.: Consulting Fees, Honoraria; Novartis Pharmaceuticals Corporation: Consulting Fees, Honoraria; Onyx Pharmaceuticals, Inc.: Consulting Fees, Honoraria; Pfizer, Inc.: Consulting Fees, Honoraria.

Staff Disclosures
The activity planning staff listed below has no relevant financial relationships to disclose:

NCCN: Mark Geisler; Kristina M. Gregory, RN, MSN, OCN; Kristin Kline Hasson; Rose Joyce; Karen Kanefield; Joan S. McClure, MS; Diane McPherson; Melanie Moletzsky; Deborah Moonan, RN, BSN; Lisa Perfidio; Liz Rieder; Shannon K. Ryan; Kathy Smith; Jennifer McCann Weckesser  

PRIME: Keith Whitener

The clinical information team listed below, who have reviewed content, has the following relevant financial relationships to disclose:

NCCN:
Courtney Smith, PhD: Johnson & Johnson: Equity Interest/Stock Options; Opko Health, Inc: Equity Interest/Stock Options

PRIME:
Tamar Sapir, PhD: Salary/Contractual
Cherilyn Heggen-Peay, PhD: Salary/Contractual

The ACCME/ANCC/ACPE defines “conflict of interest” as when an individual has an opportunity to affect CE content about products or services of a commercial interest with which he/she has a financial relationship.

ACCME, ACPE, and ANCC focuses on financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content of the CE activity. ACCME, ACPE, and ANCC have not set a minimal dollar amount for relationships to be significant. Inherent in any amount is the incentive to maintain or increase the value of the relationship. The ACCME, ACPE, and ANCC defines “’relevant’ financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation to the tasks and methods of delivery.